Outcomes of PRF on Septoplasty in Patient With Nasal Septal Deviation
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 65
SponsorKafrelsheikh University
About this trial
The aim of this study is to assess the effectiveness of Platelet-Rich Fibrin (PRF) in improving postoperative healing, reducing complications, and enhancing functional outcomes in patients undergoing septoplasty
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adults aged 18-65 years undergoing septoplasty. Presence of cartilage deviated nasal septum requiring repair. No contraindications to PRF therapy.
Disqualifiers
History of coagulopathy or anticoagulant therapy. Active infection or systemic disease. Known hypersensitivity to PRF components. Previous nasal surgery Autoimmune or systemic inflammatory disease
Trial design
Design model
Parallel
Treatments tested in this trial
Effect of Platelet Rich Fibrin on Septoplasty
Other interventionit is a randomized trial of usage of platelet rich fibrin in septoplasty
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: platelet rich fibrinActive comparator 1 intervention
Group B: control groupActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Effect of submucoperichondrial application of platelet rich fibrin on healing of nasal septum mucosa after septoplasty
Mucosal Healing will be assessed by visual nasal endscope
Time frame
postoperative at 1st week , 1st month , 3rd monthLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: